Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening?
Authors: Ned Calonge
Journal: Annals of Internal Medicine (2009)

Letters3 February 2009Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening?Ned Calonge, MD, MPH, Diana B. Petitti, MD, MPH, and Kenneth W. Lin, MDNed Calonge, MD, MPHFrom Colorado Department of Public Health and Environment, Denver, CO 80246; Keck School of Medicine, University of Southern California, Los Angeles, CA 90089; and Agency for Healthcare Research and Quality, Rockville, MD 20850., Diana B. Petitti, MD, MPHFrom Colorado Department of Public Health and Environment, Denver, CO 80246; Keck School of Medicine, University of Southern California, Los Angeles, CA 90089; and Agency for Healthcare Research and Quality, Rockville, MD 20850., and Kenneth W. Lin, MDFrom Colorado Department of Public Health and Environment, Denver, CO 80246; Keck School of Medicine, University of Southern California, Los Angeles, CA 90089; and Agency for Healthcare Research and Quality, Rockville, MD 20850.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-150-3-200902030-00020 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We appreciate the letters from Drs. Konety and colleagues and Dr. Gogol regarding the USPSTF's updated recommendation on screening for prostate cancer (1). The USPSTF recommended against screening men age 75 years or older.First, it is important to emphasize that a systematic review conducted in collaboration with the USPSTF (2) identified no direct evidence (that is, evidence from randomized trials) that permitted the USPSTF to determine whether prostate-specific antigen screening has a net benefit on mortality for men of any age. Although some men may benefit from earlier detection of potentially fatal cases of prostate cancer, others ...References1. U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:185-91. [PMID: 18678845] LinkGoogle Scholar2. Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:192-9. [PMID: 18678846] LinkGoogle Scholar3. Bill-Axelson A, Holmberg L, Ruutu M, Häggman M, Andersson SO, Bratell S, et al; Scandinavian Prostate Cancer Group Study No. 4. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977-84. [PMID: 15888698] CrossrefMedlineGoogle Scholar4. Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, et al; Scandinavian Prostate Cancer Group Study Number 4. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst. 2008;100:1144-54. [PMID: 18695132] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Colorado Department of Public Health and Environment, Denver, CO 80246; Keck School of Medicine, University of Southern California, Los Angeles, CA 90089; and Agency for Healthcare Research and Quality, Rockville, MD 20850.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoScreening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation StatementBenefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force Kenneth Lin , Robert Lipsitz , Therese Miller , and Supriya Janakiraman Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening? Badrinath R. Konety , Matthew R. Cooperberg , and Peter R. Carroll Are Age-Based Criteria the Best Way to Determine Eligibility for Prostate Cancer Screening? Manfred Gogol Metrics Cited bySkin cancer screening – better safe than sorryA Stretchable and Flexible Cardiac Tissue–Electronics Hybrid Enabling Multiple Drug Release, Sensing, and StimulationConflicts and Contradictions in Current Skin Cancer Screening GuidelinesNew Perspectives on Dietary-derived Treatments and Food Safety—Antinomy in a New EraManagement of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspectiveCardiovascular Disease in Patient-Centered Medical Homes: The Trident ApproachGene-Environment Interactions and the Risk of Childhood Acute Lymphoblastic Leukemia: Exploring the Role of Maternal Folate Genes and Folic Acid FortificationAn aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleedsStatins in the primary prevention of cardiovascular diseaseHealth behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study 3 February 2009Volume 150, Issue 3Page: 221-222KeywordsAntigensCancer screeningCancer treatmentLife expectancyProstate cancerProstatectomyRadical prostatectomySystematic reviews ePublished: 3 February 2009 Issue Published: 3 February 2009 Copyright & PermissionsCopyright © 2009 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...